(Q48132543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Marica Eoli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Elena Lamperti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Paola Gaviani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Anna Fiumani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Andrea Salmaggi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Chiara Falcone

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Graziella Filippini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Andrea Botturi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Amerigo Boiardi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

19 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

143-151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17576523%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-007-9427-y

1 January 2020

exact match

0 references

cites work

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9427-Y

How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9427-Y

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9427-Y

PCV chemotherapy for recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9427-Y

Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9427-Y

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

21 January 2018

1 reference

12 December 2020

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

12 December 2020

Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

1 reference

12 December 2020

NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94).

1 reference

12 December 2020

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

1 reference

12 December 2020

Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life

1 reference

12 December 2020

Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy

1 reference

12 December 2020

Procarbazine in haematology: an old drug with a new life?

1 reference

12 December 2020

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

1 reference

12 December 2020

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

1 reference

12 December 2020

O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts

1 reference

12 December 2020

Fotemustine combined with procarbazine in recurrent malignant gliomas: a phase I study with evaluation of lymphocyte 06-alkylguanine-DNA alkyltransferase activity.

1 reference

12 December 2020

Optimal two-stage designs for phase II clinical trials

1 reference

12 December 2020

Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study.

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Salvage therapy in patients with glioblastoma: is there any benefit?

1 reference

12 December 2020

Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates

1 reference

12 December 2020

Phase II study of fotemustine in recurrent supratentorial malignant gliomas

1 reference

12 December 2020

Changing paradigms--an update on the multidisciplinary management of malignant glioma

1 reference

12 December 2020

Can O6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic?

1 reference

12 December 2020

Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

1 reference

12 December 2020

Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas

1 reference

12 December 2020

Salvage chemotherapy with taxol for recurrent anaplastic astrocytomas

1 reference

12 December 2020

Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme

1 reference

12 December 2020

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

12 December 2020

MGMT: its role in cancer aetiology and cancer therapeutics

1 reference

12 December 2020

Permeability of two nitrosoureas, carmustine and fotemustine in rat cortex

1 reference

12 December 2020

Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial

1 reference

12 December 2020

Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme

1 reference

12 December 2020

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

12 December 2020

Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

1 reference

12 December 2020

Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients

1 reference

12 December 2020

Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

12 December 2020